Keyphrases
Moderate to Severe
100%
Atopic Dermatitis
100%
Subgroup Analysis
100%
Crisaborole
100%
Investigator's Static Global Assessment
55%
Pediatric Patients
44%
Baseline Characteristics
22%
Application Site
22%
Age Groups
11%
Safety Concerns
11%
Phase II Study
11%
Twice Daily
11%
Patient Subgroups
11%
Success Rate
11%
Disease Severity
11%
Patients Included
11%
Body Surface Area
11%
Global Diseases
11%
Treatment-related
11%
Non-steroidal
11%
Ointment
11%
Grade Improvement
11%
Phosphodiesterase 4 Inhibitor
11%
All Pediatric
11%
Nursing and Health Professions
Crisaborole
100%
Atopic Dermatitis
100%
Pediatrics Patient
44%
Disease Severity
11%
Randomization
11%
Post Hoc Analysis
11%
Surface Area
11%
Ointment
11%
Phosphodiesterase-4 Inhibitor
11%
Bovine Serum Albumin
11%
Agricultural and Biological Sciences
Surface Area
100%
Bovine Serum Albumin
100%
Phosphodiesterase
100%
Pharmacology, Toxicology and Pharmaceutical Science
Crisaborole
100%
Application Site Discomfort
11%
Application Site Pain
11%
Medicine and Dentistry
Crisaborole
100%
Application Site Pain
11%
Application Site Discomfort
11%